RARE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RARE Market Cap History RARE YTD Return |
RARE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RARE Market Cap History RARE YTD Return |
RARE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+11.28% CAGR Mouse over chart for data details
|
RARE Stock Price Chart |
About Ultragenyx Pharmaceutical Inc |
Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia. We show 43 historical shares outstanding datapoints in our coverage of RARE's shares outstanding history. Understanding the changing numbers of RARE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RARE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RARE by allowing them to research RARE shares outstanding history as well as any other stock in our coverage universe. |
RARE Current Stock Quote |
Free RARE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
RARE Share Performance |
Shares Outstanding Peers |
Ultragenyx Pharmaceutical (RARE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RARX Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.